Immunochemotherapy of malignant glioma: synergistic activity of CD95 ligand and chemotherapeutics.
Roth, W
Immunochemotherapy of malignant glioma: synergistic activity of CD95 ligand and chemotherapeutics. [electronic resource] - Cancer immunology, immunotherapy : CII Mar 1997 - 55-63 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0340-7004
10.1007/s002620050355 doi
Antineoplastic Agents--administration & dosage
Apoptosis
Brain Neoplasms--therapy
Combined Modality Therapy
Glioma--therapy
Humans
Proto-Oncogene Proteins c-bcl-2--metabolism
Tumor Cells, Cultured
Tumor Suppressor Protein p53--metabolism
fas Receptor--therapeutic use
Immunochemotherapy of malignant glioma: synergistic activity of CD95 ligand and chemotherapeutics. [electronic resource] - Cancer immunology, immunotherapy : CII Mar 1997 - 55-63 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0340-7004
10.1007/s002620050355 doi
Antineoplastic Agents--administration & dosage
Apoptosis
Brain Neoplasms--therapy
Combined Modality Therapy
Glioma--therapy
Humans
Proto-Oncogene Proteins c-bcl-2--metabolism
Tumor Cells, Cultured
Tumor Suppressor Protein p53--metabolism
fas Receptor--therapeutic use